Etubics Employee Directory

Biotechnology ResearchWashington, United States2-10 Employees

Etubics Corporation is a early-stage biotechnology research company based in Seattle, Washington, focused on developing vaccines and immunotherapies using a patented adenovirus delivery platform and a validated human cell line. Its work aims to address limitations of traditional adenovirus products, including overcoming pre-existing immunity, enabling repeated immunization, and allowing protection against multiple diseases in a single recipient. The company has progressed to Phase I/IIa with its lead product, ETBX-011, an immunotherapeutic for colorectal cancer, and has reported positive preliminary data from animal and human studies without notable safety concerns. A notable recent development includes securing a national institute of health grant to pursue research and development in related therapeutic areas such as HIV/HPV-associated head and neck cancers. Etubics operates within the biotechnology research sector, pursuing a platform approach that supports diverse product opportunities and rapid development in immunotherapies and vaccines.

Sign up for free to view info

Company overview Email format